Hybrid Director, Market Development bei Ardelyx
Ardelyx · Waltham, Vereinigte Staaten Von Amerika · Hybrid
- Senior
- Optionales Büro in Waltham
Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada.
- Contribute early commercial insights on market potential, product differentiation, target patient groups, and the competitive landscape into the business development process
- Identify adjacent commercial opportunities that leverage existing platforms or capabilities
- Provide early insights into market potential, product differentiation, target patient populations, and competitors
- Develop and deliver executive-level presentations, provide visibility into product development progress, resource allocation, and strategic priorities
- Collaborate closely with R&D, Medical Affairs, Market Access, and Regulatory teams to shape commercial strategies throughout the product lifecycle
- Act as the commercial leader in cross-functional launch teams, establishing structure through governance and decision-making processes. Lead scenario planning, market shaping, and positioning efforts
- Develop and implement program strategies and operational frameworks to ensure efficiency in product development, launch readiness, and resource allocation
- Develop and validate TPPs and clinical endpoints aligned with evolving market standards and expectations
- Monitor industry trends, competitor pipeline activities, and new therapies to identify commercial risks and opportunities
- Create and execute insight generation plans to support strategic decisions as programs advance
- Collaborate with internal stakeholders to inform commercial assessments, ensuring alignment with governance and prioritization frameworks
- Support launch readiness by developing go-to-market plans, setting KPIs, and tracking key milestones
- Bachelor’s degree in business or a related field with 9 - 12 years of experience working in business development, commercial strategy, or market development roles within biotech or pharmaceutical companies or equivalent experience
- MBA, PharmD or other advanced degree strongly preferred
- Ability to navigate ambiguity, prioritize competing business needs, and execute product strategies in a fast-paced environment
- Strong executive presentation skills, with the ability to effectively communicate with senior leadership and drive cross-functional alignment
- Strong ability to translate scientific innovation into executable product strategies, ensuring alignment with corporate goals and market demands
- Expertise in data analytics, business intelligence tools, and product lifecycle management to drive strategic portfolio decisions and optimize development pathways
- Strong knowledge of market access, reimbursement pathways, and health economics in the United States
- Experience launching or supporting commercial strategy for early-stage products
- Demonstrated ability to work cross-functionally, with strong communication, negotiation, and presentation skills
- Strategic mindset with the ability to assess complex markets and identify high-impact opportunities
- Comfortable working in a dynamic and sometimes ambiguous environment
- Willingness to travel as needed, approximately 10%